Phenotypic presentation of frontotemporal dementia with Parkinsonism-chromosome 17 type P301S in a patient of Jewish-Algerian origin

Movement Disorders

Volumn 18, Issue 5, 2003, Pages 595-598

  Werber, Edith ^a   Klein, Colin ^a   Grünfeld, Jonathan ^a   Rabey, José Martin ^a  

^a ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

Chromosome 17; P301S mutation

Indexed keywords

LEVODOPA; SELEGILINE;

ADULT; ALGERIA; ARTICLE; BABINSKI REFLEX; BRADYKINESIA; CASE REPORT; CHROMOSOME 17; CHROMOSOME MUTATION; CLINICAL FEATURE; COGNITIVE DEFECT; DISEASE COURSE; DRUG RESPONSE; FAMILY HISTORY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENETIC ANALYSIS; HUMAN; JEW; MUSCLE RIGIDITY; MUTISM; NEUROLOGIC EXAMINATION; PARKINSONISM; PHENOTYPE; PRIORITY JOURNAL; SPASTICITY; SPEECH DISORDER;

ADULT; ATROPHY; CHROMOSOMES, HUMAN, PAIR 17; COGNITION DISORDERS; FEMALE; FRONTAL LOBE; GENE ORDER; HUMANS; PARKINSON DISEASE; PHENOTYPE; POINT MUTATION; REFLEX, BABINSKI; TEMPORAL LOBE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0038147249     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10401     Document Type: Article

References (19)

1. Lynch T, Sano M, Marder KS, et al. Clinical characteristics of a family with chromosome 17 linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology 1994;44:1878-1884.
2. Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998;393:702-705.
3. Spillantini MG, Van Sweiten JC, Goedert M. Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Neurogenetics 2000;2:193-205.
4. Spillantini MG, Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci 1998;21:428-433.
5. Bird TD, Nochlin D. Poorkaj P, et al. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301L). Brain 1999;122:741-756.
6. Mirra SS, Murrell JR, Gearing M, et al. Tau pathology in a family with dementia and a P301L mutation in tau. J Neuropathol Exp Neurol 1999;58:335-345.
7. Bugiani O, Murrell JR, Giaccone G, et al. Frontotemporal dementia and corticobasal degeneration in a family with a P301S mutation in tau. J Neuropathol Exp Neurol 1999;58:667-677.
8. Hong M, Zhukareva V, Vogelsberg-Ragaglia V, et al. Mutation-specific functional impairments in distinct tau-isoforms of hereditary FTDP-17. Science 1998;282:1917-4.
9. Pickering-Brown SM, Richardson AM, Snowden JS, et al. Inherited frontotemporal dementia in nine British families associated with intronic mutations in the tau gene. Brain 2002;125:732-751.
10. Morris HR, Khan MN, Janssen JC, et al. The genetic and pathological classification of familial frontotemporal dementia. Arch Neurol 2001;58:1813-1816.
11. Sperfeld AD, Collatz MB, Baier H, et al. FTDP-17: an early phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Ann Neurol 1999;46:708-715.
12. Yasuda M, Yokoyama K, Nakayasu T, et al. A Japanese patient with frontotemporal dementia and parkinsonism by a Tau P301S mutation. Neurology 2000;55:1224-1227.
13. Poorkaj P, Bird TD, Wijsman E, et al. Tau is a candidate gene for chromosome 17 frontotemporal dementia. Ann Neurol 1998;43: 815-825.
14. Wszolek ZK, Pfeiffer RF, Bhatt MH, et al. Rapidly progressive autosomal dominant parkinsonism and dementia with pallidoponto nigral degeneration. Ann Neurol 1992;32:312-320.
15. Cordes M, Wszolek ZK, Calne DB, Rodnitzky RL, Pfeiffer RF. Magnetic resonance imaging studies in rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto nigral degeneration. Neurodegeneration 1992;1:217-224.
16. Wijker M, Wszolek ZK, Wolters E, et al. Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral-degeneration to chromosome 17q21. Hum Mol Gen 1996;1:151-154.
17. Pal PK, Wszolek DK, Kishore A, et al. Positron emission tomography in pallido-ponto nigral degeneration (PPND) family (frontotemporal dementia with parkinsonism linked to chromosome 17 and point mutation in tau gene). Parkinsonism Relat Disord 2001; 7:81-88.
18. Nasreddine ZS, Loginov M, Clark LN, et al. From genotype to phenotype: a clinical pathological, and biochemical investigation of frontotemporal dementia and parkinsonism (FTDP-17) caused by the P301L tau mutation. Ann Neurol 1999;45:704-715.
19. Reed LA, Zbigniew K, Wszolek Z, Hutton M. Phenotypic correlations in FTDP-17. Neurobiol Aging 2001;22:89-107.